14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
×
Home
/
Stock Analysis
/
Compare Terminal
/
NMR vs MFG
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
NMR vs MFG: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
MFG Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 6–3 Matrix Metrics)
MFG Overall Winner
6-Pillar Tally: NMR 1 – 4 MFG (1 Tie)
Matrix Metrics: NMR 3 – 6 MFG
As of Nov 17, 2026, Mizuho Financial Group, Inc. (MFG) is the stronger overall head-to-head candidate over Nomura Holdings, Inc (NMR) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). NMR carries a Unified Composite Score of 44.5/100 (HOLD) at $9.34 (12.7x Forward P/E, 25.1% operating margin), whereas MFG carries 55.7/100 (HOLD) at $9.79 (15.1x Forward P/E, 40.0% operating margin).
NMR
NYSE
Nomura Holdings, Inc
Security Brokers, Dealers & Flotation Companies
Market Cap
$28.3B
TTM Revenue
$14.9B
Forward P/E
12.7x
Beta / 30D Vol
1.03β · 29% Vol
Unified Composite Score
44.5 / 100
HOLD
Tech 47.0
Fund 49.0
Flow 50.0
Mom 50.0
Weinstein Technical Phase
Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 45.5 · SMA20: $9.40 · SMA50: $9.68
MFG
NYSE
Head-to-Head Winner
Mizuho Financial Group, Inc. American Depositary Shares (Each representing one-fifth of an Ordinary Share)
National Commercial Banks
Market Cap
$124.8B
TTM Revenue
$31.2B
Forward P/E
15.1x
Beta / 30D Vol
1.32β · 38% Vol
Unified Composite Score
55.7 / 100
HOLD
Tech 45.0
Fund 47.0
Flow 50.0
Mom 50.0
Weinstein Technical Phase
Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 45.3 · SMA20: $9.80 · SMA50: $10.40
6-Pillar Scorecard Institutional Category Breakdown (NMR 1 – 4 MFG)
Columns: Metric · NMR · MFG
1. Valuation Multiples
NMR
Forward P/E
12.7x
15.1x
Trailing P/E
11.2x
13.6x
PEG Ratio
0.81x
1.13x
EV / Revenue
1.9x
4.0x
2. Growth & Scale
MFG
Revenue Growth (YoY)
+17.9%
+17.8%
Earnings Growth (YoY)
+13.6%
+21.7%
TTM Revenue (USD)
$14.9B
$31.2B
Market Cap
$28.3B
$124.8B
3. Profitability & Quality
MFG
Gross Margin
77.4%
100.0%
Operating Margin
25.1%
40.0%
Net Profit Margin
17.1%
29.4%
Return on Equity (ROE)
11.5%
13.1%
4. Balance Sheet & Cash Flow
MFG
Cash Generation (TTM)
N/A
N/A
Cash Flow Margin
N/A
N/A
Net Cash / Leverage
$8.17 Book/Sh · 11.5% ROE
$5.86 Book/Sh · 13.1% ROE
Dividend Yield
3.34%
1.78%
5. Options & Positioning
Tie
Options Structure Phase
UNCLASSIFIED
UNCLASSIFIED
Current IV / %ile
30.7% (<1st %ile)
23.1% (50th %ile)
Put/Call OI Skew
Thin ADR Chain
Thin ADR Chain
OBV Trend / Tech Phase
NEUTRAL · Neutral
NEUTRAL · Neutral
6. R&D & Supply-Chain Moat
MFG
OpEx & R&D Intensity
52.3% of Rev ($7.77B)
60.0% of Rev ($18.7B)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Scale & Operating Efficiency Moat
High-Margin Pricing Power Moat
Supply-Chain Role
Capital Markets Operator
Banks - Regional Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: NMR (3) vs MFG (6)
Institutional Metric
NMR
MFG
Criterion
Row Edge
Market Capitalization
Scale
$28.3B
$124.8B
Larger Scale
MFG
Trailing P/E Ratio
Valuation
11.2x
13.6x
Lower Multiple
NMR
Forward P/E Ratio
Valuation
12.7x
15.1x
Lower Multiple
NMR
Revenue Growth (YoY)
Growth
+17.9%
+17.8%
Higher Growth
Tie
Operating Margin (TTM)
Profitability
25.1%
40.0%
Higher Margin
MFG
Net Profit Margin
Profitability
17.1%
29.4%
Higher Margin
MFG
Return on Equity (ROE)
Capital Efficiency
11.5%
13.1%
Higher ROE
MFG
52-Week Range Position
Momentum
60% ($7–$11)
66% ($6–$11)
Stronger Trend
MFG
Beta / 30D Volatility
Risk Regime
1.03β · 29% Vol
1.32β · 38% Vol
Lower Realized Risk
NMR
Unified Institutional Score
Composite Signal
44.5 / 100 (HOLD)
55.7 / 100 (HOLD)
Higher Composite
MFG
Trailing 12M Revenue (USD)
Operating Scale
$14.9B
$31.2B
FX-Normalized USD
Scale
Gross Profit Margin (TTM)
Unit Pricing Power
77.4%
100.0%
Higher Margin
Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.81x PEG · 1.9x EV/Rev
1.13x PEG · 4.0x EV/Rev
Lower Multiple
Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($8.17 Book/Sh · 11.5% ROE)
N/A ($5.86 Book/Sh · 13.1% ROE)
Higher Cash / Net Cash
Solvency
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M
3M
6M
1Y
1M Horizon
NMR +5.09 pp
NMR:
+2.36%
·
MFG:
-2.73%
3M Horizon
NMR +1.56 pp
NMR:
-1.84%
·
MFG:
-3.4%
6M Horizon
NMR +3.97 pp
NMR:
+16.69%
·
MFG:
+12.72%
1Y Horizon
MFG +12.62 pp
NMR:
+26.32%
·
MFG:
+38.94%
Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)
Split-Invariant USD Revenue & Operating Margin (%)
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NMR vs MFG. Trailing 12-month operating profitability (NMR 25.1% vs MFG 40.0%) and valuation multiples (NMR 12.7x vs MFG 15.1x Forward P/E) are benchmarked directly in Pillar 4 below.
NMR ADR TTM Benchmark
FX-Normalized USD
TTM Revenue $14.9B
Gross Margin 77.4%
Op. Margin 25.1%
ROE / Fwd P/E 11.5% · 12.7x
MFG ADR TTM Benchmark
FX-Normalized USD
TTM Revenue $31.2B
Gross Margin 100.0%
Op. Margin 40.0%
ROE / Fwd P/E 13.1% · 15.1x
NMR
UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV
30.7%
IV Percentile
<1st %ile
Put/Call OI Skew
Thin ADR Chain
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
MFG
UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV
23.1%
IV Percentile
50th %ile
Put/Call OI Skew
Thin ADR Chain
IV Regime
Balanced (25th–60th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
NMR Moat Profile
Scale & Operating Efficiency Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $28.3B market capitalization and 25.1% operating margin.
OpEx & R&D Reinvestment
52.3% of Rev ($7.77B)
90D Engineering Disclosures
0 Published
MFG Moat Profile
High-Margin Pricing Power Moat
Banks - Regional Operator
Competes within the Banks - Regional value chain with $124.8B market capitalization and 40.0% operating margin.
OpEx & R&D Reinvestment
60.0% of Rev ($18.7B)
90D Engineering Disclosures
0 Published
Investor FAQ NMR vs MFG Key Questions & Quantitative Answers
Is NMR or MFG a better stock to buy right now?
As of Nov 17, 2026, Mizuho Financial Group, Inc. (MFG) is the stronger overall head-to-head candidate over Nomura Holdings, Inc (NMR) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). NMR carries a Unified Composite Score of 44.5/100 (HOLD) at $9.34 (12.7x Forward P/E, 25.1% operating margin), whereas MFG carries 55.7/100 (HOLD) at $9.79 (15.1x Forward P/E, 40.0% operating margin). Technically, NMR sits in a Neutral phase (RSI 45.5, UNCLASSIFIED options structure) and MFG sits in a Neutral phase (RSI 45.3, UNCLASSIFIED options structure).
Does NMR or MFG have stronger revenue and earnings growth?
MFG leads the Growth & Scale pillar: NMR posts +17.9% YoY revenue growth and +13.6% YoY earnings growth on $14.9B TTM revenue (77.4% gross margin, 25.1% operating margin), compared with MFG at +17.8% YoY revenue growth and +21.7% YoY earnings growth on $31.2B TTM revenue (100.0% gross margin, 40.0% operating margin). On trailing 12-month operating scale, NMR generates $14.9B in USD-normalized revenue versus $31.2B for MFG. In operating R&D and SG&A reinvestment, NMR deploys 52.3% of Rev ($7.77B) (0 90-day corporate R&D disclosures) versus 60.0% of Rev ($18.7B) (0 disclosures) for MFG.
Is NMR or MFG cheaper on valuation?
NMR screens cheaper on headline valuation multiples. NMR trades at 12.7x Forward P/E, 11.2x Trailing P/E, 0.81x PEG, and 1.9x EV/Revenue (unreported cash flow margin), whereas MFG trades at 15.1x Forward P/E, 13.6x Trailing P/E, 1.13x PEG, and 4.0x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NMR (11.5% ROE) versus MFG (13.1% ROE) capital efficiency.
How is options market volatility positioned on NMR vs MFG?
In options market volatility and institutional positioning, NMR carries 30.7% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.03β · 29% Vol realized risk). By comparison, MFG carries 23.1% implied volatility (50th %ile, Balanced (25th–60th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.32β · 38% Vol realized risk).
Nomura Holdings, Inc (NMR) Research Suite
Mizuho Financial Group, Inc. American Depositary Shares (Each representing one-fifth of an Ordinary Share) (MFG) Research Suite
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.